Medtronic PLC (MDT)
Return on equity (ROE)
| Apr 26, 2024 | Apr 28, 2023 | Apr 29, 2022 | Apr 30, 2021 | Apr 24, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 3,676,000 | 3,758,000 | 5,039,000 | 3,606,000 | 4,789,000 |
| Total stockholders’ equity | US$ in thousands | 50,214,000 | 51,483,000 | 52,551,000 | 51,428,000 | 50,737,000 |
| ROE | 7.32% | 7.30% | 9.59% | 7.01% | 9.44% |
April 26, 2024 calculation
ROE = Net income ÷ Total stockholders’ equity
= $3,676,000K ÷ $50,214,000K
= 7.32%
Over the past five years, Medtronic PLC's return on equity (ROE) has shown some fluctuations. In the most recent fiscal year ended April 26, 2024, the ROE stood at 7.32%, which was slightly higher compared to the previous year's ROE of 7.30%. However, it was lower than the ROE reported in fiscal year 2022, which was 9.59%.
The ROE for fiscal year 2021 was 7.01%, and for fiscal year 2020, it was 9.44%. The company's ROE has generally been in the range of 7% to 9.59% over the past five years.
Overall, the ROE indicates how efficiently Medtronic PLC is utilizing its shareholders' equity to generate profits. The fluctuations in ROE over the years may suggest changes in the company's profitability, asset management, or capital structure. Investors and analysts may want to further investigate the factors influencing these fluctuations to gain a better understanding of the company's financial performance and future prospects.
Peer comparison
Apr 26, 2024